Cheng Zhang

Dr. Cheng Zhang is an Instructor in the Department of Pathology at UT Southwestern Medical Center. He holds a Ph.D. in Cell Biology from Zhejiang University and specializes in cancer biology, molecular mechanisms of m6A modification, and tumor immunotherapy. His research focuses on renal carcinoma, bispecific antibodies, and PROTAC molecules. Dr. Zhang employs advanced techniques such as CRISPR and next-generation sequencing, and has mentored graduate students, postdoctoral fellows, and technicians.

Education:

• Ph.D. in Cell Biology, Zhejiang University

Research Interests:

Dr. Zhang’s work centers on oncology and molecular biology, particularly the role of m6A modification in renal carcinoma and the development of therapeutic strategies. His studies integrate epigenetic regulation, immunotherapy, and precision medicine, with a focus on translational research to improve patient outcomes.

Publications:

His recent works include studies on VHL tumor suppressor mechanisms, oncogenic signaling pathways in renal cancer, and mitochondrial membrane biology. These publications highlight advancements in understanding renal carcinoma biology and therapeutic targets for immunotherapy and epigenetic modulation.

Advising & Grants:

Dr. Zhang has a proven track record in mentoring early-career researchers and fostering collaborative environments. His research has been supported by grants focused on cancer biology and therapeutic development.

Labs/Teams:

He contributes to collaborative research initiatives at UT Southwestern, emphasizing interdisciplinary approaches to cancer research and precision medicine.